Increased plasma pro-inflammatory cytokine concentrations after myocardial infarction and the presence of depression during next 6-months;Wzrost stężenia cytokin prozapalnych w osoczu pacjentów po zawale mięs̈nia sercowego a obecnos̈ć depresji w okresie następnych 6 miesięcy

Psychiatria Polska

Volumn 49, Issue 3, 2015, Pages 455-464

  Wilkowska, Alina ^a   Pikuła, Michał ^b   Rynkiewicz, Andrzej ^a   Wdowczyk Szulc, Joanna ^a   Trzonkowski, Piotr ^b   Landowski, Jerzy ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Zak ad Immunologii Klinicznej i Transplantologii GUM   (Poland)

Author keywords

Depression; Myocardial infarction; Pro inflammatory cytokines

Indexed keywords

INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE; INTERLEUKIN 12;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; INFLAMMATION; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; BLOOD; COMPARATIVE STUDY; COMPLICATION; CONTROLLED CLINICAL TRIAL; FEMALE; MALE; MIDDLE AGED;

BIOMARKERS; CYTOKINES; DEPRESSION; FEMALE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84936773779     PISSN: 00332674     EISSN: 23915854     Source Type: Journal    
DOI: 10.12740/PP/33179     Document Type: Article

References (37)

1. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of twelvemonth DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch. Gen. Psychiatry 2005; 62(6): 617-627.
2. Kessler RC, Berglund PA, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch. Gen. Psychiatry 2005; 62(6): 593-602.
3. Lesperance F, Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J. Psychosom. Res. 2000; 48: 379-391.
4. Dudek D, Siwek M, Datka W, Wróbel A, Zięba A. Dynamika objawów depresyjnych u pacjentów z chorobą niedokrwienną serca, poddanych zabiegom przezskórnej angioplastyki wieńcowej. Psychiatr. Pol. 2007; 41(2): 217-227.
5. Thombs B, Bass E. Prevalence of depression in survivors of acute myocardial infarction. Review of the evidence. J. Gen. Intern. Med. 2006; 2: 30-38.
6. Schleifer SJ, Macari-Hinson MM, Coyle DA, Slater WR, Kahn M, Gorlin R. i wsp. The nature and course of depression following myocardial infarction. Arch. Intern. Med. 1989; 149: 1785-1789.
7. Kroemeke A. Dynamika objawów depresji po zawale serca - znaczenie zmian w poziomie nadziei. Psychiatr. Pol. 2013; 47(5): 799-810.
8. Borowiecka-Kluza J, Miernik-Jaeshke M, Jaeshke R, Siwek M, Dudek D. Brzemię rodziny chorych z zaburzeniami afektywnymi - zarys problemu. Psychiatr. Pol. 2013; 47(4): 635-646.
9. Gidron Y, Gilutz H, Berger R, Huleihel M. Molecular and cellular interface between behavior and acute coronary syndromes. Cardiovasc. Res. 2002; 56(1): 15-21.
10. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK. i wsp. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010; 67: 446-457.
11. Służewska A, Rybakowski J, Sobieska M. Aktywacja układu immunologicznego w depresji endogennej. Psychiatr. Pol. 1996; 30(5): 771-782.
12. Belmaker RH, Agam G. Major depressive disorder. N. Engl. J. Med. 2008; 358: 55-58.
13. Frasure-Smith N, Lespérance F, Irwin M, Sauvé C, Lespérance J, Théroux P. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol. Psychiatry 2007; 62(4): 302-308.
14. Tulner D, Smith O, Schins A, de Jonge P, Quere M, Delanghe J. i wsp. Antidepressive effect of mirtazapine in post-myocardial infarction depression is associated with soluble TNF-R1 increase: data from the MIND-IT. Neuropsychobiology 2011; 63(3): 169-176.
15. Liu H, Luiten PG, Eisel U, Dejongste M, Schoemaker R. Depression after myocardial infarction: TNF-α-induced alterations of the blood-brain barrier and its putative therapeutic implications. Neurosci. Biobehav. Rev. 2013; 37(4): 561-572.
16. First, M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press, Inc.; 1996.
17. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56-62.
18. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 4: 561-571.
19. StatsDirect v. 2.8.0. http://www.statsdirect.com [dostęp: 16.04.2015].
20. Kosmala W, Przewłocka-Kosmala M. Proinflammatory cytokines and myocardial viability in patients after acute myocardial infarction. Int. J. Cardiol. 2005; 101(3): 449-456.
21. Ohtsuka T, Hamada M. Relation of circulating Interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction. Clin. Cardiol. 2004; 27: 417-420.
22. Hartford M, Wiklund O. CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up. Int. J. Cardiol. 2006; 108: 55-62.
23. Karpiński Ł, Płaksej R, Derzhko R, Orda A, Witkowska M. Serum levels of interleukin-6, interleukin-10 and C-reactive protein in patients with myocardial infarction treated with primary angioplasty during a 6-month follow-up. Pol. Arch. Intern. Med. 2009; 119: 115-121.
24. Correia LC, Andrade BB, Borges VM, Clarêncio J, Bittencourt AP, Freitas R. i wsp. Prognostic value of cytokines and chemokines in addition to the GRACE Score in non-ST-elevation acute coronary syndromes. Clin. Chim. Acta 2010; 411: 540-545.
25. Ji QW, Guo M, Zheng JS, Mao XB, Peng YD, Li SN. i wsp. Downregulation of T helper cell type 3 in patients with acute coronary syndrome. Arch. Med. Res. 2009; 40: 285-293.
26. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT. i wsp. The Th17/Treg imbalance in patients with acute coronary syndromes. Clin. Immunol. 2008; 127: 89-97.
27. Chen Y, Jiang T, Chen P, Ouyang J, Xu G, Zeng Z. i wsp. Emerging tendency towards autoimmune process in major depressive patients: a novel insight from Th17 cells. Psychiatry Res. 2011; 188: 224-230.
28. Matusik P, Guzik B, Weber C, Guzik T. Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice? Thromb. Haemost. 2012; 108(3): 443-456.
29. Howren B, Lamkin D. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009; 71: 171-186.
30. Maes M, Scharpe S, Meltzer HY, Bosmans E, Suy E, Calabrese J. i wsp. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res. 1993; 49: 11-27.
31. Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF - alpha) and soluble interleukin-2 receptors (sIL-2R) a reelevated in patients with major depressive disorder: ameta-analysis and meta-regression. J. Affect. Disord. 2012; 139: 230-239.
32. Corcoran M, Meydani M, Lichtenstein A, Schaefer E, Dillard A, Lamon-Fava1 S. Sex hormone modulation of proinflammatory cytokine and CRP expression in macrophages from older men and postmenopausal women. J. Endocrinol. 2010; 206(2): 217-224.
33. Cartier A, Côté M, Lemieux I, Pérusse L, Tremblay A, Bouchard C. i wsp. Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am. J. Clin. Nutr. 2009; 89: 1307-1314.
34. Irwin M, Carrillo C, Olmstead R. Sleep loss activates cellular markers of inflammation: Sex differences. Brain Behav. Immun.2010; 24(1): 54-57.
35. Lichtenegger F, Mueller K, Otte B, Beck B, Hiddemann W, Schendel D. i wsp. CD86 and IL-12p70 are key players for T helper 1 polarization and natural killer cell activation by toll-like receptor-induced dendritic cells. PLoS One 2012; 7(9): e44266.
36. Imamura M, Targino RA, Hsing WT, Imamura S, Azevedo RS, Boas LS. i wsp. Concentration of cytokines in patients with osteoarthritis of the knee and fibromyalgia. Clin. Interv. Aging 2014; 9: 939-944.
37. Jie J, von Schéele I, Bergström J, Billing B, Dahlén B, Lantz AS. i wsp. Compartment differences of inflammatory activity in chronic obstructive pulmonary disease. Respir. Res. 2014; 15(1): 104.